Drug delivery from ocular implants (Q36409058)

14 August 2017

1 reference

title

Drug delivery from ocular implants (English)

1 reference

14 August 2017

1 reference

Tsutomu Yasukawa

1

1 reference

14 August 2017

Yuichiro Ogura

2

1 reference

14 August 2017

Hideya Kimura

3

1 reference

14 August 2017

Eiji Sakurai

4

1 reference

14 August 2017

Yasuhiko Tabata

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Drug Delivery

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

261-273

1 reference

14 August 2017

2

1 reference

Transscleral drug delivery to the retina and choroid

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Transscleral drug delivery for posterior segment disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Scleral plug of biodegradable polymers for controlled drug release in the vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable polymers for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable microspheres for vitreoretinal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Release of human serum albumin from poly(lactide-co-glycolide) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable scleral plugs for vitreoretinal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable scleral implant for intravitreal controlled release of fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Drug delivery systems for vitreoretinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

Protein release from gelatin matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.261

21 January 2018

Identifiers

DOI

10.1517/17425247.3.2.261

1 reference

14 August 2017

1 reference